1.82
0.12 (7.06%)
0.12 (7.06%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.81
High
5.80
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.12 | 7.06% | 1.82 | 19:56:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.7437 | 1.67 | 1.80 | 1.74 | 1.70 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.77 | 1.82 | 0.05 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,460 | 5,140,085 | $ 1.75 | $ 8,987,183 | 20,260,958 | 0.81 - 5.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:55 | 1 | $ 1.82 | USD |
Atossa Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 129.95M | 71.40M | 71.35M | $ - | $ - | -2.04 | -1.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.86 | 1.91 | 1.48 | 1.62 | 5,709,859 | -0.04 | -2.15% |
| 1 Month | 2.10 | 2.295 | 1.48 | 1.96 | 6,309,029 | -0.28 | -13.33% |
| 3 Months | 2.25 | 4.90 | 1.48 | 3.03 | 15,991,474 | -0.43 | -19.11% |
| 6 Months | 1.89 | 4.90 | 0.81 | 2.41 | 13,946,658 | -0.07 | -3.7% |
| 1 Year | 2.12 | 5.80 | 0.81 | 2.44 | 7,159,349 | -0.30 | -14.15% |
| 3 Years | 3.57 | 7.39 | 0.755 | 2.66 | 2,873,158 | -1.75 | -49.02% |
| 5 Years | 50.40 | 73.80 | 0.755 | 4.38 | 2,312,098 | -48.58 | -96.39% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The clinical-Stage Programs of the company includes delivery of therapeutics through microcatheters which delivers a number of therapeutics to the ducts in the breast, the site of the majority of early breast cancers and fulvestrant Delivered through microcatheters which delivers fulvestrant as a potential treatment of ductal carcinoma in-situ (DCIS) and breast cancer. In addition, the company involves in the process of evaluating additional potential indications of endoxifen and other therapeutic candidates to treat breast conditions, including breast cancer. |
